Table 2. Clonal type-specific anti-peptide reactivity of T. gondii positive humans.
Peptide specificity | Acute patients (n = 21) | Non-acute patients (n = 53) | Volunteers (forest workers) (n = 100) | Total (n = 174) | ||||
n | % | n | % | n | % | n | % | |
I | 9 | 43 | 26 | 49 | 38 | 38 | 73 | 42 |
II | 19 | 91 | 38 | 72 | 67 | 67 | 124 | 71 |
III | 2 | 10 | 8 | 15 | 18 | 18 | 28 | 16 |
I–II | 2 | 10 | 9 | 17 | 14 | 14 | 25 | 14 |
I–III | 15 | 71 | 19 | 36 | 28 | 28 | 62 | 36 |
II–III | 19 | 91 | 30 | 57 | 36 | 3 | 85 | 49 |
Reactions are sorted according to the specificities of peptides.